M-478

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameM-478
Drug Alias NameM-478
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionBeta Lactamase inhibitorstype I signal peptidase inhibitors
TargetsBeta Lactamasetype I signal peptidase
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Research Laboratories
Active IndicationsN/A
Inactive IndicationsStaphylococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A